For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| TA-7284-Low | TA-7284 50 mg, once daily for 12 weeks | None | None | 1 | 82 | 36 | 82 | View |
| TA-7284-Low-middle | TA-7284 100 mg, once daily for 12 weeks | None | None | 0 | 74 | 34 | 74 | View |
| TA-7284-High-middle | TA-7284 200 mg, once daily for 12 weeks | None | None | 0 | 77 | 38 | 77 | View |
| TA-7284-High | TA-7284 300 mg, once daily for 12 weeks | None | None | 0 | 75 | 34 | 75 | View |
| Placebo | TA-7284 Placebo, once daily for 12 weeks | None | None | 0 | 75 | 26 | 75 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Lung adenocarcinoma | None | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 13.0 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Bronchitis | None | Infections and infestations | MedDRA 13.0 | View |
| Enteritis infectious | None | Infections and infestations | MedDRA 13.0 | View |
| Gastroenteritis | None | Infections and infestations | MedDRA 13.0 | View |
| Hordeolum | None | Infections and infestations | MedDRA 13.0 | View |
| Localised infection | None | Infections and infestations | MedDRA 13.0 | View |
| Nasopharyngitis | None | Infections and infestations | MedDRA 13.0 | View |
| Pharyngitis | None | Infections and infestations | MedDRA 13.0 | View |
| Pilonidal cyst | None | Infections and infestations | MedDRA 13.0 | View |
| Rhinitis | None | Infections and infestations | MedDRA 13.0 | View |
| Stitch abscess | None | Infections and infestations | MedDRA 13.0 | View |
| Upper respiratory tract infection bacterial | None | Infections and infestations | MedDRA 13.0 | View |
| Vulvitis | None | Infections and infestations | MedDRA 13.0 | View |
| Vulvovaginal candidiasis | None | Infections and infestations | MedDRA 13.0 | View |
| Decreased appetite | None | Metabolism and nutrition disorders | MedDRA 13.0 | View |
| Dehydration | None | Metabolism and nutrition disorders | MedDRA 13.0 | View |
| Hyperlipidaemia | None | Metabolism and nutrition disorders | MedDRA 13.0 | View |
| Hypoglycaemia | None | Metabolism and nutrition disorders | MedDRA 13.0 | View |
| Hypoglycaemia unawareness | None | Metabolism and nutrition disorders | MedDRA 13.0 | View |
| Depressive symptom | None | Psychiatric disorders | MedDRA 13.0 | View |
| Middle insomnia | None | Psychiatric disorders | MedDRA 13.0 | View |
| Dizziness | None | Nervous system disorders | MedDRA 13.0 | View |
| Facial palsy | None | Nervous system disorders | MedDRA 13.0 | View |
| Hypoaesthesia | None | Nervous system disorders | MedDRA 13.0 | View |
| Sciatica | None | Nervous system disorders | MedDRA 13.0 | View |
| Conjunctival haemorrhage | None | Eye disorders | MedDRA 13.0 | View |
| Conjunctivitis | None | Eye disorders | MedDRA 13.0 | View |
| Conjunctivitis allergic | None | Eye disorders | MedDRA 13.0 | View |
| Glaucoma | None | Eye disorders | MedDRA 13.0 | View |
| Vertigo | None | Ear and labyrinth disorders | MedDRA 13.0 | View |
| Atrial fibrillation | None | Cardiac disorders | MedDRA 13.0 | View |
| Palpitations | None | Cardiac disorders | MedDRA 13.0 | View |
| Hypertension | None | Vascular disorders | MedDRA 13.0 | View |
| Peripheral coldness | None | Vascular disorders | MedDRA 13.0 | View |
| Cough | None | Respiratory, thoracic and mediastinal disorders | MedDRA 13.0 | View |
| Epistaxis | None | Respiratory, thoracic and mediastinal disorders | MedDRA 13.0 | View |
| Hiccups | None | Respiratory, thoracic and mediastinal disorders | MedDRA 13.0 | View |
| Rhinorrhoea | None | Respiratory, thoracic and mediastinal disorders | MedDRA 13.0 | View |
| Upper respiratory tract inflammation | None | Respiratory, thoracic and mediastinal disorders | MedDRA 13.0 | View |
| Abdominal discomfort | None | Gastrointestinal disorders | MedDRA 13.0 | View |
| Abdominal distension | None | Gastrointestinal disorders | MedDRA 13.0 | View |
| Abdominal pain | None | Gastrointestinal disorders | MedDRA 13.0 | View |
| Abdominal pain upper | None | Gastrointestinal disorders | MedDRA 13.0 | View |
| Cheilitis | None | Gastrointestinal disorders | MedDRA 13.0 | View |
| Constipation | None | Gastrointestinal disorders | MedDRA 13.0 | View |
| Dental caries | None | Gastrointestinal disorders | MedDRA 13.0 | View |
| Diarrhoea | None | Gastrointestinal disorders | MedDRA 13.0 | View |
| Dyspepsia | None | Gastrointestinal disorders | MedDRA 13.0 | View |
| Gastritis | None | Gastrointestinal disorders | MedDRA 13.0 | View |
| Gastritis erosive | None | Gastrointestinal disorders | MedDRA 13.0 | View |
| Gingivitis | None | Gastrointestinal disorders | MedDRA 13.0 | View |
| Haemorrhoids | None | Gastrointestinal disorders | MedDRA 13.0 | View |
| Nausea | None | Gastrointestinal disorders | MedDRA 13.0 | View |
| Oral discomfort | None | Gastrointestinal disorders | MedDRA 13.0 | View |
| Periodontitis | None | Gastrointestinal disorders | MedDRA 13.0 | View |
| Tongue discolouration | None | Gastrointestinal disorders | MedDRA 13.0 | View |
| Vomiting | None | Gastrointestinal disorders | MedDRA 13.0 | View |
| Alopecia areata | None | Skin and subcutaneous tissue disorders | MedDRA 13.0 | View |
| Dermatitis | None | Skin and subcutaneous tissue disorders | MedDRA 13.0 | View |
| Dermatitis atopic | None | Skin and subcutaneous tissue disorders | MedDRA 13.0 | View |
| Dermatitis contact | None | Skin and subcutaneous tissue disorders | MedDRA 13.0 | View |
| Eczema | None | Skin and subcutaneous tissue disorders | MedDRA 13.0 | View |
| Eczema asteatotic | None | Skin and subcutaneous tissue disorders | MedDRA 13.0 | View |
| Pruritus | None | Skin and subcutaneous tissue disorders | MedDRA 13.0 | View |
| Urticaria | None | Skin and subcutaneous tissue disorders | MedDRA 13.0 | View |
| Arthralgia | None | Musculoskeletal and connective tissue disorders | MedDRA 13.0 | View |
| Arthritis | None | Musculoskeletal and connective tissue disorders | MedDRA 13.0 | View |
| Back pain | None | Musculoskeletal and connective tissue disorders | MedDRA 13.0 | View |
| Bone pain | None | Musculoskeletal and connective tissue disorders | MedDRA 13.0 | View |
| Intervertebral disc protrusion | None | Musculoskeletal and connective tissue disorders | MedDRA 13.0 | View |
| Joint stiffness | None | Musculoskeletal and connective tissue disorders | MedDRA 13.0 | View |
| Muscle spasms | None | Musculoskeletal and connective tissue disorders | MedDRA 13.0 | View |
| Musculoskeletal stiffness | None | Musculoskeletal and connective tissue disorders | MedDRA 13.0 | View |
| Myalgia | None | Musculoskeletal and connective tissue disorders | MedDRA 13.0 | View |
| Periarthritis | None | Musculoskeletal and connective tissue disorders | MedDRA 13.0 | View |
| Spinal osteoarthritis | None | Musculoskeletal and connective tissue disorders | MedDRA 13.0 | View |
| Hypertonic bladder | None | Renal and urinary disorders | MedDRA 13.0 | View |
| Pollakiuria | None | Renal and urinary disorders | MedDRA 13.0 | View |
| Urinary incontinence | None | Renal and urinary disorders | MedDRA 13.0 | View |
| Benign prostatic hyperplasia | None | Reproductive system and breast disorders | MedDRA 13.0 | View |
| Dysmenorrhoea | None | Reproductive system and breast disorders | MedDRA 13.0 | View |
| Menopausal symptoms | None | Reproductive system and breast disorders | MedDRA 13.0 | View |
| Pruritus genital | None | Reproductive system and breast disorders | MedDRA 13.0 | View |
| Vulvar erosion | None | Reproductive system and breast disorders | MedDRA 13.0 | View |
| Chest discomfort | None | General disorders | MedDRA 13.0 | View |
| Chest pain | None | General disorders | MedDRA 13.0 | View |
| Hunger | None | General disorders | MedDRA 13.0 | View |
| Malaise | None | General disorders | MedDRA 13.0 | View |
| Thirst | None | General disorders | MedDRA 13.0 | View |
| Activated partial thromboplastin time prolonged | None | Investigations | MedDRA 13.0 | View |
| Alanine aminotransferase increased | None | Investigations | MedDRA 13.0 | View |
| Blood creatine phosphokinase increased | None | Investigations | MedDRA 13.0 | View |
| Blood ketone body increased | None | Investigations | MedDRA 13.0 | View |
| Blood lactate dehydrogenase increased | None | Investigations | MedDRA 13.0 | View |
| Blood triglycerides increased | None | Investigations | MedDRA 13.0 | View |
| Blood urine present | None | Investigations | MedDRA 13.0 | View |
| Electrocardiogram abnormal | None | Investigations | MedDRA 13.0 | View |
| Platelet count decreased | None | Investigations | MedDRA 13.0 | View |
| Protein urine present | None | Investigations | MedDRA 13.0 | View |
| Urine output increased | None | Investigations | MedDRA 13.0 | View |
| Weight decreased | None | Investigations | MedDRA 13.0 | View |
| White blood cell count decreased | None | Investigations | MedDRA 13.0 | View |
| Arthropod sting | None | Injury, poisoning and procedural complications | MedDRA 13.0 | View |
| Contusion | None | Injury, poisoning and procedural complications | MedDRA 13.0 | View |
| Foot fracture | None | Injury, poisoning and procedural complications | MedDRA 13.0 | View |
| Joint sprain | None | Injury, poisoning and procedural complications | MedDRA 13.0 | View |
| Muscle strain | None | Injury, poisoning and procedural complications | MedDRA 13.0 | View |
| Open wound | None | Injury, poisoning and procedural complications | MedDRA 13.0 | View |
| Rib fracture | None | Injury, poisoning and procedural complications | MedDRA 13.0 | View |
| Tongue injury | None | Injury, poisoning and procedural complications | MedDRA 13.0 | View |